Mutations of p53, c-kit, K-ras, and β-catenin gene in non-Hodgkin's lymphoma of adrenal gland

被引:17
作者
Nakatsuka, S
Hongyo, T
Syaifudin, M
Nomura, T
Shingu, N
Aozasa, K
机构
[1] Osaka Univ, Grad Sch Med, Dept Pathol, Suita, Osaka 5650871, Japan
[2] Osaka Univ, Grad Sch Med, Dept Radiat Biol, Suita, Osaka 5650871, Japan
来源
JAPANESE JOURNAL OF CANCER RESEARCH | 2002年 / 93卷 / 03期
关键词
adrenal lymphoma; p53; c-kit; K-ras; beta-catenin;
D O I
10.1111/j.1349-7006.2002.tb02168.x
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Malignant lymphoma of the adrenal gland is a rare disease, usually with diffuse large cell morphology and B-cell immunophenotype, and often associated with Epstein-Barr virus infection. In this study, mutations of p53, c-kit, K-ras, and beta-catenin gene were analyzed in 17 cases (13 males and four females with ages ranging from 25 to 84 years) of such lymphomas by polymerase chain reaction-single strand conformation polymorphism followed by direct sequencing. Selected exons in each gene, representing hot spots, were analyzed. All 44 mutations detected were single-nucleotide substitutions and 33 were missense mutations. Nineteen mutations were detected in exon 5 and/or 7 of the p53 gene in nine of 17 cases (52.9%) and 21 in exon 11 and/or 17 of the c-kit gene in 10 of 14 cases (71.4%). Bilateral adrenal lesions in one case who had not received any adjuvant therapy showed different mutational patterns of the p53 and c-kit genes, suggesting different clonal evolution of lymphoma between the left and right sides. Mutation at codon 13 of the K-ras gene was detected in one of 14 cases (7.1%), and in exon 3 of the beta-catenin gene in three of 12 cases (25%). All but one mutation were transition mutations, indicating that some endogenous mutagens act in lymphomagenesis in the adrenal gland. Our results suggest that p53 and c-kit gene mutations might play a role in adrenal lymphomagenesis.
引用
收藏
页码:267 / 274
页数:8
相关论文
共 40 条
[1]  
ABERLE H, 1994, J CELL SCI, V107, P3655
[2]  
ABRAHAMSON JLA, 1995, MOL CELL BIOL, V15, P6953
[3]   P53 MUTATION AND EXPRESSION IN LYMPHOMA [J].
ADAMSON, DJA ;
THOMPSON, WD ;
DAWSON, AA ;
BENNETT, B ;
HAITES, NE .
BRITISH JOURNAL OF CANCER, 1995, 72 (01) :150-154
[4]   Primary bilateral adrenal lymphoma [J].
Al-Fiar, FZ ;
Pantalony, D ;
Shepherd, F .
LEUKEMIA & LYMPHOMA, 1997, 27 (5-6) :543-549
[5]   RAS ONCOGENES - THEIR ROLE IN NEOPLASIA [J].
BARBACID, M .
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 1990, 20 (03) :225-235
[6]   Functional interaction of beta-catenin with the transcription factor LEF-1 [J].
Behrens, J ;
vonKries, JP ;
Kuhl, M ;
Bruhn, L ;
Wedlich, D ;
Grosschedl, R ;
Birchmeier, W .
NATURE, 1996, 382 (6592) :638-642
[7]   Mutations with loss of heterozygosity of p53 are common in therapy-related myelodysplasia and acute myeloid leukemia after exposure to alkylating agents and significantly associated with deletion or loss of 5q, a complex karyotype, and a poor prognosis [J].
Christiansen, DH ;
Andersen, MK ;
Pedersen-Bjergaard, J .
JOURNAL OF CLINICAL ONCOLOGY, 2001, 19 (05) :1405-1413
[8]  
de La Coste A, 1998, P NATL ACAD SCI USA, V95, P8847
[9]   Genomic aberrations and survival in chronic lymphocytic leukemia. [J].
Döhner, H ;
Stilgenbauer, S ;
Benner, A ;
Leupolt, E ;
Kröber, A ;
Bullinger, L ;
Döhner, K ;
Bentz, M ;
Lichter, P .
NEW ENGLAND JOURNAL OF MEDICINE, 2000, 343 (26) :1910-1916
[10]   MICE DEFICIENT FOR P53 ARE DEVELOPMENTALLY NORMAL BUT SUSCEPTIBLE TO SPONTANEOUS TUMORS [J].
DONEHOWER, LA ;
HARVEY, M ;
SLAGLE, BL ;
MCARTHUR, MJ ;
MONTGOMERY, CA ;
BUTEL, JS ;
BRADLEY, A .
NATURE, 1992, 356 (6366) :215-221